Moorestown, NJ, United States of America

Norman Ruetsch

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Mind of Norman Ruetsch: Pioneering Humanized Antibodies

Introduction: Norman Ruetsch, an accomplished inventor based in Moorestown, NJ, has made significant contributions to the field of biomedicine with his innovative work on humanized anti-CXCR5 antibodies. With a total of six patents to his name, Ruetsch's inventions are at the forefront of new treatments aimed at addressing CXCR5-related diseases.

Latest Patents: Among Norman Ruetsch's recent innovations are two notable patents for humanized anti-CXCR5 antibodies. These inventions focus on antibodies that specifically bind to CXCR5, effectively inhibiting its function. The potential applications of these antibodies include the treatment and prevention of various diseases and disorders linked to CXCR5, showcasing Ruetsch's dedication to addressing critical healthcare issues.

Career Highlights: Currently, Norman Ruetsch is a valuable member of the team at Sanofi, a global healthcare leader known for its focus on innovative solutions and therapies. His work in developing cutting-edge antibodies emphasizes his commitment to advancing medical science and improving patient outcomes.

Collaborations: Throughout his career, Ruetsch has collaborated with talented professionals, including coworkers Renata Lee and Vincent Mikol. These partnerships highlight the collaborative spirit of innovation within the scientific community, fostering advancements that significantly impact public health.

Conclusion: Norman Ruetsch's work exemplifies the intersection of innovation and healthcare. With six patents and a focus on developing humanized antibodies, his contributions are poised to make a difference in the treatment of CXCR5-related diseases. As he continues to work with esteemed colleagues at Sanofi, the future of biomedical advancements looks promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…